HopeStage
Back to all studies
RecruitingNCT05869682

Bright-light therapy during prostate cancer treatment: fatigue and mood study

About this titleRead the official source — NCT05869682
Medication studyAges 60+United StatesDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: from 60 years.

What will I do during this study?

Participants continue standard prostate-cancer treatment and are randomly assigned to start bright-white-light glasses immediately or after six months. The immediate group uses the glasses for 12 months; the delayed group uses them for the final six months. The study follows participants for 52 weeks and collects fatigue, mood and quality-of-life measures.

Listed locations
DuarteSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 9, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
210
Sponsor
City of Hope Medical Center
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug, OTHER, PROCEDURE
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
Over 60 Years
Official registry ID
NCT05869682
Official title
Show the full official title

Phase 2 Study of Bright White Light During Treatment With ADT Combination Therapy in Men With Advanced Prostate Cancer to PreServe PHysIcal and MeNtal HEalth (SHINE)

Recruitment & locations

Currently recruiting

Duarte

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is City of Hope Medical Center, a hospital or academic medical center.

Who can participate?

Listed age limits: from 60 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies